Katalysen Ventures

The Board of Directors considers that the subscription price reflects the nature of the transaction. The unique structure of the transaction, which will result in the Company receiving approximately 4,000 new shareholders, would be significantly more costly to achieve through alternative methods. The amount exceeding the quota value of the shares shall be allocated to the unrestricted share premium reserve.

The reason for executing the directed issue and to deviate from the shareholders' preferential rights are as follows:

The Board of Directors has examined and carefully evaluated a range of alternatives to increase the Company's shareholder dispersion. Based on this assessment, the Board concludes that there are no favorable conditions to carry out a rights issue that would achieve an equal or comparable result. A directed share issue to Dividend Sweden AB, which intends to distribute 75% of the allotted shares to its own shareholders,is assessed to be the most time- and cost-efficient method to broaden the Company's shareholder base. The Board further considers that the new shareholders are likely to contribute material long-term value. Overall, the Board finds that the reasons for deviating from shareholders' preferential rights outweigh the reasons supporting the main rule, and that the directed share issue is in the best interests of the Company and all shareholders.

Effects on share capital and dilution

Through the directed issue, the number of shares and votes in Katalysen will increase by 277,777, from 9,609,441 to 9,887,218. The share capital increases by SEK 36,111.01, from SEK 1,249,227.33 to SEK 1,285,338.34.

The directed issue results in a dilution of approximately 2,9% for existing shareholders, based on the total number of shares and votes after the issue.

The transaction is conditional upon the extraordinary general meeting of Dividend Sweden AB resolving to distribute the received shares to its shareholders.